Advances in nanotechnology for cancer biomarkers
Fei Ye, Ying Zhao, Ramy El-Sayed, Mamoun Muhammed, Moustapha Hassan
Index: 10.1016/j.nantod.2017.12.008
Full Text: HTML
Abstract
Cancer biomarkers with high selectivity, specificity and reproducibility play essential role in diagnosis, prognosis and prediction of treatment efficacy in cancer patients. However, the current biomarker assays used in clinics could be improved due to low sensitivity and specificity. Nanoparticle-based assays are emerging as an upcoming approach, providing ultra-high sensitivity and specificity in cancer biomarker detection. The current survey presents an overview of strategies used in the development and integration of nanoparticles for cancer biomarker detection, including mass spectrometry, optical and electrical detection methods. Moreover, we discuss the future trends in the field in correlation to new approaches from fundamental and practical standpoints.
Latest Articles:
Recent advances in functional nanomaterials for light–triggered cancer therapy
2018-03-13
[10.1016/j.nantod.2018.02.010]
Recent progress on the photocatalysis of carbon dots: Classification, mechanism and applications
2018-03-12
[10.1016/j.nantod.2018.02.008]
Colloidal aggregation: From screening nuisance to formulation nuance
2018-03-10
[10.1016/j.nantod.2018.02.011]
Two-dimensional transition metal dichalcogenide hybrid materials for energy applications
2018-03-07
[10.1016/j.nantod.2018.02.007]
Guiding Rules for Selecting a Nanothermometer
2018-03-07
[10.1016/j.nantod.2018.02.012]